BRPI0823113A2 - Método para tratamento de artrite reumatóide, tremores/doença de parkinson, esclerose múltipla e câncer de origem não virais. - Google Patents

Método para tratamento de artrite reumatóide, tremores/doença de parkinson, esclerose múltipla e câncer de origem não virais.

Info

Publication number: BRPI0823113A2
Authority: BR; Brazil
Prior art keywords: tremors; parkinson; cancer; disease; treatment
Prior art date: 2008-09-26

Application number

BRPI0823113-3A

Other languages

English (en)

Inventor

George Nelson

Original Assignee

Salubrious Pharmaceuticals LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-09-26

Filing date

2008-10-14

Publication date

2015-06-16

2008-10-14 Application filed by Salubrious Pharmaceuticals LLC filed Critical Salubrious Pharmaceuticals LLC

2015-06-16 Publication of BRPI0823113A2 publication Critical patent/BRPI0823113A2/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/38—Antigens from snakes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0823113-3A 2008-09-26 2008-10-14 Método para tratamento de artrite reumatóide, tremores/doença de parkinson, esclerose múltipla e câncer de origem não virais. BRPI0823113A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/US2008/011233 WO2010036226A1 (en)	2008-09-26	2008-09-26	Process for treatment of rheumatoid arthritis, tremors/parkinson's disease and multiple sclerosis
PCT/US2008/011775 WO2010036230A1 (en)	2008-09-26	2008-10-14	Process for treatment of rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis and non-viral based cancers

Publications (1)

Publication Number	Publication Date
BRPI0823113A2 true BRPI0823113A2 (pt)	2015-06-16

Family

ID=42059975

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0823113-3A BRPI0823113A2 (pt)	2008-09-26	2008-10-14	Método para tratamento de artrite reumatóide, tremores/doença de parkinson, esclerose múltipla e câncer de origem não virais.

Country Status (15)

Country	Link
EP (1)	EP2334325B1 (pt)
JP (1)	JP2012503652A (pt)
KR (1)	KR20110079816A (pt)
CN (1)	CN102264384A (pt)
AU (1)	AU2008362160A1 (pt)
BR (1)	BRPI0823113A2 (pt)
CA (1)	CA2775062A1 (pt)
DK (1)	DK2334325T3 (pt)
ES (1)	ES2622863T3 (pt)
IL (1)	IL211957A0 (pt)
MA (1)	MA32730B1 (pt)
NZ (1)	NZ592481A (pt)
RU (1)	RU2011118869A (pt)
WO (2)	WO2010036226A1 (pt)
ZA (1)	ZA201103070B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8017634B2 (en)	2003-12-29	2011-09-13	President And Fellows Of Harvard College	Compositions for treating obesity and insulin resistance disorders
US20100330117A1 (en) *	2008-09-26	2010-12-30	Salubrious Pharmaceutical, Llc	Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c
US9877981B2 (en)	2012-10-09	2018-01-30	President And Fellows Of Harvard College	NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation
WO2015069860A1 (en) *	2013-11-06	2015-05-14	President And Fellows Of Harvard College	Biological production of nad precursors and analogs
UA125788C2 (uk) *	2014-10-07	2022-06-08	Серум Інстітют Оф Індія Прайвт Лімітед	Спосіб інактивації ентеровірусу, ад'ювант адсорбції та композиція із зменшеною дозою вакцини, одержана з ним

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69530196T2 (de) *	1994-06-02	2003-11-20	Elan Drug Delivery Ltd	Methode zum verhindern der aggregation von proteinen/peptiden bei rehydratation oder auftauen
US20030157129A1 (en) *	1995-06-23	2003-08-21	Smithkline Beecham Biologicals S.A.	Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein
US6190669B1 (en) *	1998-05-13	2001-02-20	University Of Maryland, Baltimore	Attenuated mutants of salmonella which constitutively express the Vi antigen
WO2001025254A2 (en)	1999-10-04	2001-04-12	University Of Maryland Biotechnology Institute	Novel adjuvant comprising a lipopolysaccharide antagonist
SE0301109D0 (sv) *	2003-04-14	2003-04-14	Mallen Huang	Nucleotide vaccine composition
JP2008509072A (ja) *	2004-02-06	2008-03-27	マヨファウンデーションフォーメディカルエデュケーションアンドリサーチ	改良型ワクチン用のポリペプチド‐アジュバント複合体
US20060045884A1 (en) *	2004-08-26	2006-03-02	Board Of Regents	Vaccines for autoimmune and infectious disease
HUE034269T2 (en) *	2005-12-29	2018-02-28	Janssen Biotech Inc	Human anti-IL-23 antibodies, preparations, methods and applications
WO2007126546A1 (en) *	2006-03-30	2007-11-08	Cogenesys, Inc.	Fusion proteins comprising alpha fetoprotein
EP2121139B1 (en) *	2007-01-16	2012-10-10	BiPar Sciences, Inc.	Formulations for cancer treatment

2008
- 2008-09-26 WO PCT/US2008/011233 patent/WO2010036226A1/en not_active Ceased
- 2008-10-14 CA CA2775062A patent/CA2775062A1/en not_active Abandoned
- 2008-10-14 RU RU2011118869/15A patent/RU2011118869A/ru not_active Application Discontinuation
- 2008-10-14 ES ES08816736.6T patent/ES2622863T3/es active Active
- 2008-10-14 JP JP2011528993A patent/JP2012503652A/ja active Pending
- 2008-10-14 CN CN200880132113XA patent/CN102264384A/zh active Pending
- 2008-10-14 WO PCT/US2008/011775 patent/WO2010036230A1/en not_active Ceased
- 2008-10-14 NZ NZ592481A patent/NZ592481A/xx not_active IP Right Cessation
- 2008-10-14 AU AU2008362160A patent/AU2008362160A1/en not_active Abandoned
- 2008-10-14 BR BRPI0823113-3A patent/BRPI0823113A2/pt not_active IP Right Cessation
- 2008-10-14 DK DK08816736.6T patent/DK2334325T3/en active
- 2008-10-14 KR KR1020117009409A patent/KR20110079816A/ko not_active Withdrawn
- 2008-10-14 EP EP08816736.6A patent/EP2334325B1/en not_active Not-in-force
2011
- 2011-03-27 IL IL211957A patent/IL211957A0/en unknown
- 2011-04-26 ZA ZA2011/03070A patent/ZA201103070B/en unknown
- 2011-04-26 MA MA33797A patent/MA32730B1/fr unknown

Also Published As

Publication number	Publication date
RU2011118869A (ru)	2012-11-10
WO2010036230A1 (en)	2010-04-01
WO2010036226A1 (en)	2010-04-01
EP2334325A1 (en)	2011-06-22
EP2334325B1 (en)	2017-03-15
DK2334325T3 (en)	2017-06-26
CN102264384A (zh)	2011-11-30
ZA201103070B (en)	2011-12-28
NZ592481A (en)	2012-12-21
ES2622863T3 (es)	2017-07-07
CA2775062A1 (en)	2010-04-01
JP2012503652A (ja)	2012-02-09
MA32730B1 (fr)	2011-10-02
KR20110079816A (ko)	2011-07-08
EP2334325A4 (en)	2015-08-12
IL211957A0 (en)	2011-06-30
AU2008362160A1 (en)	2010-04-01

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0814941A2 (pt)	2014-09-30	Composição de tratamentode semente, e, método de tratamento de semente.
BRPI1006145A2 (pt)	2017-05-30	"composição e método para tratamento de diabetes".
BRPI0914902A2 (pt)	2017-06-20	composição farmacêutica e método para tratamento de mal de parkinson
BRPI0817271A2 (pt)	2015-06-16	Método de tratamento da doença de parkinson e outros distúrbios relacionados
BRPI0922122A2 (pt)	2017-08-01	composições e métodos para tratamento de doença celíaca.
EP1885864A4 (en)	2011-04-13	PROCESS FOR THE CONTINUOUS TREATMENT OF LIGNOCELLULOSIC RAW MATERIALS
BRPI1012339A2 (pt)	2018-07-24	"aparelho de decodificador temporário e método."
DK2350093T3 (da)	2012-11-12	Substituerede 4,5,6,7-tetrahydrothienopyridiner som KCNQ2/3-modulatorer til behandling af smerte, epilepsi og urininkontinens.
AP2011005631A0 (en)	2011-04-30	Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment.
BRPI0911612A2 (pt)	2015-12-15	composições e métodos para o tratamento da esclerose múltipla.
ZA200907356B (en)	2010-08-25	Tapentadol for treating pain from arthritis
EP2418737A4 (en)	2014-01-22	CRIMP TERMINAL, CRIMP STRUCTURE FOR A CRIMP TERMINAL, AND METHOD FOR CRIMPING A CRIMP TERMINAL
BR112013003529A2 (pt)	2016-06-28	"composição aerada, composição de tratamento capilar método para o tratamento capilar"
FR2932486B1 (fr)	2012-12-07	Procede de preparation d'un polyamideimide, polyamideimide et composition comprenant ce polyamideimide.
BR112012003464A2 (pt)	2015-09-08	composto, composição farmacêutica, usos de uma composição farmacêutica e de um composto, e, método para tratar uma doença ou um distúrbio."
BRPI0820440A2 (pt)	2015-05-26	Inibidores aldh-2 no tratamento de desordens psiquiátricas
BRPI0813764A2 (pt)	2014-12-30	Processo para formação de haletos de carbonila alfa, beta-insaturados
EP2279206A4 (en)	2011-05-25	PROCESS FOR PREVENTING RHEUMATOID ARTHRITIS IN PERSONS WITH UNDIFFERENCED ARTHRITIS
WO2010091384A3 (en)	2011-03-24	Cadherin-11 inhibitors and methods of use thereof
BRPI0818170A2 (pt)	2017-05-16	5-cianotienopiridinas para o tratamento de tumores.
EP2540867A4 (en)	2014-01-22	SURFACE-TREATED STEEL PLATE, METHOD OF MANUFACTURING THEREFOR AND FABRICATED STEEL PLATE THEREWITH
WO2008100621A3 (en)	2008-12-11	Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s
BRPI0823113A2 (pt)	2015-06-16	Método para tratamento de artrite reumatóide, tremores/doença de parkinson, esclerose múltipla e câncer de origem não virais.
IL213120A0 (en)	2011-07-31	Method for treating parkinson' s disease
BRPI0822905A2 (pt)	2015-06-30	Método para o tratamento de produtos, e, câmara climática.